Back
Monte Rosa Therapeutics Stock Price Chart
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
34
GLUE
Monte Rosa Therapeutics
Last Price:
8.49
Seasonality Move:
-8.98%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.- The current trend is moderately bullish and GLUE is experiencing selling pressure, which indicates risk of future bearish movement.
Monte Rosa Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.27 | Sell |
| 20-day SMA: | 7.8 | Buy |
| 50-day SMA: | 6.45 | Buy |
| 200-day SMA: | 5.53 | Buy |
| 8-day EMA: | 9.03 | Sell |
| 20-day EMA: | 8.12 | Buy |
| 50-day EMA: | 6.86 | Buy |
| 200-day EMA: | 5.74 | Buy |
Monte Rosa Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.99 | Buy |
| Relative Strength Index (14 RSI): | 58.16 | Buy |
| Chaikin Money Flow: | -662051 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.15 - 9.31) | Buy |
| Bollinger Bands (100): | (3.88 - 7.18) | Buy |
Monte Rosa Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monte Rosa Therapeutics Stock
Is Monte Rosa Therapeutics Stock a Buy?
- Monte Rosa Therapeutics share price is 8.63 while GLUE 8-day simple moving average is 9.27, which is a Sell signal.
- The stock price of GLUE is 8.63 while Monte Rosa Therapeutics 20-day SMA is 7.80, which makes it a Buy.
- Monte Rosa Therapeutics 50-day simple moving average is 6.45 while GLUE share price is 8.63, making it a Buy technically.
- GLUE stock price is 8.63 and Monte Rosa Therapeutics 200-day simple moving average is 5.53, creating a Buy signal.
GLUE Technical Analysis vs Fundamental Analysis
Sell
34
Monte Rosa Therapeutics (GLUE)
is a Sell
Is Monte Rosa Therapeutics a Buy or a Sell?
-
Monte Rosa Therapeutics stock is rated a Sell
The current Monte Rosa Therapeutics [GLUE] share price is $8.63. The Score for GLUE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Monte Rosa Therapeutics Stock Info
Market Cap:
529.34M
Price in USD:
8.63
Share Volume:
668.88K
Monte Rosa Therapeutics 52-Week Range
52-Week High:
12.40
52-Week Low:
2.91
Sell
34
Monte Rosa Therapeutics (GLUE)
is a Sell
Monte Rosa Therapeutics Share Price Forecast
-
What is the Monte Rosa Therapeutics stock price today?
The Monte Rosa Therapeutics stock price is 8.63 USD today. -
Will GLUE stock go up or go down?
Monte Rosa Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Monte Rosa Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monte Rosa Therapeutics is overvalued.
Is Monte Rosa Therapeutics Stock a Buy?
- Monte Rosa Therapeutics share price is 8.63 while GLUE 8-day exponential moving average is 9.03, which is a Sell signal.
- The stock price of GLUE is 8.63 while Monte Rosa Therapeutics 20-day EMA is 8.12, which makes it a Buy.
- Monte Rosa Therapeutics 50-day exponential moving average is 6.86 while GLUE share price is 8.63, making it a Buy technically.
- GLUE stock price is 8.63 and Monte Rosa Therapeutics 200-day simple moving average is 5.74, creating a Buy signal.
Fundamental Analysis of Monte Rosa Therapeutics
Is Monte Rosa Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and a decrease next year of $0.60 per share.
Technical Analysis of Monte Rosa Therapeutics
Should I short Monte Rosa Therapeutics stock?
- GLUE Moving Average Covergence Divergence (MACD) indicator is 0.99, suggesting Monte Rosa Therapeutics is a Buy
- Monte Rosa Therapeutics Relative Strength Index (RSI) is 58.16, which suggest Monte Rosa Therapeutics is overbought
- The Bollinger Bands (25) for Monte Rosa Therapeutics is (5.15 - 9.31), which suggest Monte Rosa Therapeutics is a Buy
- The Bollinger Bands (100) for Monte Rosa Therapeutics is (3.88 - 7.18), which suggest Monte Rosa Therapeutics is a Buy
* Monte Rosa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.